Matt Wasserman is currently the Global Access Strategy and Pricing Team Lead for Pneumococcal Vaccines at Pfizer, where they lead a team of market access experts. They have extensive experience in health economics and market access, having previously served as a Senior Director and Global Market Access Lead for pneumococcal vaccines. Matt's background includes roles as a Consultant at Double Helix Consulting and research positions at Johns Hopkins Bloomberg School of Public Health and Columbia University Medical Center. They hold an MSc in International Health Policy and Health Economics from the London School of Economics and a BA in Public Health/Economics from The Johns Hopkins University.
This person is not in any teams
This person is not in any offices